Condition
Congenital Infection
Total Trials
5
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
Trial Status
Unknown2
Recruiting1
Enrolling By Invitation1
Terminated1
Clinical Trials (5)
Showing 5 of 5 trials
NCT04398901Enrolling By Invitation
Neurodevelopmental Outcomes in ZIKV-Exposed Children
NCT04822142Recruiting
Congenital CYtoMEgalovirus Infection in VIEtnam (CYMEVIE)
NCT03922594Terminated
Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia
NCT03786497Unknown
Protecting Brains and Saving Futures - the PBSF Protocol
NCT02129465Unknown
Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy
Showing all 5 trials